Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
Crossref DOI link: https://doi.org/10.1007/s40121-023-00782-5
Published Online: 2023-03-16
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kimata, Masahiro
Watanabe, Asuka
Yanagida, Yukiko
Kinoshita, Daisuke
Maekawa, Shinichiroh
Funding for this research was provided by:
MSD K.K.
Text and Data Mining valid from 2023-03-16
Version of Record valid from 2023-03-16
Article History
Received: 14 December 2022
Accepted: 14 February 2023
First Online: 16 March 2023